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Although exercise training has been advocated as a nonpharmacological treatment for 
multiple sclerosis (MS) related fatigue, no consensus exists regarding its effectiveness. To 
address this, we collated meta-analytic reviews that explored the effectiveness of exercise 
training for the treatment of MS-related fatigue. We searched five online databases for 
relevant reviews, published since 2005, and identified 172 records. Five reviews were 
retained for systematic extraction of information and evidence quality analysis. Although 
our review synthesis indicated that exercise training interventions have a moderate effect 
on fatigue reduction in people with MS, no clear insight was obtained regarding the relative 
effectiveness of specific types or modes of exercise intervention. Moreover, Grading of 
Recommendation Assessment, Development and Evaluation revealed that the overall 
quality of evidence emanating from these five reviews was ‘very low’.
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According to the WHO report 1.3 million people, in 112 countries, have multiple sclerosis (MS) [1]. 
The symptoms of MS include emotional lability, incontinence, pain, cognitive problems, oscillopsia, 
spasticity, mobility problems and fatigue. Fatigue, the most common symptom, has been reported 
as the most troubling symptom by more than 50% of people with MS (pwMS) [2,3]. The etiology of 
Practice points
 ●  Information reviewed is largely obtained from studies of 30–50-year-old participants of moderate disability with 
nonprogressive multiple sclerosis (MS).
 ●  Exercise interventions appear to elicit a moderately favorable effect on fatigue in people with MS when compared 
with usual care or a no-exercise comparison group.
 ●  Mixed training and other types of exercise such as balance and yoga appear to show larger effects than other types 
of exercise.
 ●  There is still a lack of convincing information regarding which type of exercise intervention/s and with what specific 
combination of exercise duration, frequency and intensity might be most effective in reducing MS-related fatigue.
 ●  The results should be interpreted with caution because of high risk of bias, poor applicability of results, 
heterogeneity and small sample size in the randomized control trials on which this review of review evidence is 
ultimately based.
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fatigue is unknown, however, it is multifactorial, 
subjective in nature, can be physical and/or 
mental, secondary or primary, and interferes 
with desired and usual activities [4–6].
Recent reviews suggest that pharmacological 
intervention for treatment of fatigue has mini-
mal effect and use of nonpharmacological 
intervention such as exercise has potential merit 
for the direct management of fatigue in pwMS 
rather than merely as an adjunct treatment [7,8].
Although there is a paucity of information 
on definite mechanisms behind the effect of 
exercise training on MS fatigue, it has been sug-
gested that exercise may ameliorate primary MS 
fatigue through cardiovascular, immunologic, 
neuroendocrine and neurologic changes, while 
secondary fatigue could be affected by exercise 
as a result of symptomatic reduction in decon-
ditioning, sleep disorders and depression [9,10].
A Cochrane review on the effectiveness of 
exercise-based rehabilitation programs for MS 
by Rietberg et al. [11] concluded that there was 
evidence to support the implementation of 
exercise training as a means to improve mus-
cle power, physical function, exercise tolerance, 
mobility-related activities and mood. However, 
no evidence was found to support a role for 
exercise training on MS fatigue, possibly due 
to the limited number of studies available at 
the time of that particular review. Since then in 
excess of 60 randomized control trials (RCTs) 
have been published, reporting the effect of 
exercise therapy on patient reported fatigue 
in pwMS, mostly as secondary outcome. 
Subsequently, a number of similarly focused 
systematic/meta-analytic reviews have been 
published. Consequently, this paper aims to 
produce an overview synthesis of meta-analytic 
review-generated information about a poten-
tial role for exercise training interventions 
for MS-related fatigue. In doing so, we will 
appraise both the methodological quality of the 
included meta-analytic reviews as well as evalu-
ating the overall quality of evidence generated 
by them with a view to contribute to the debate 
around the development of future exercise 
intervention guidelines and the identification 
of future research directions.
Methods
●● Literature search
A search for relevant published reviews was 
conducted using online databases including 
Medline and Embase, both using Ovid, 
Cochrane Library, Centre for Review and 
Dissemination, and Physiotherapy Evidence 
Database (PEDro), from 2005 to October 
2016. Both Medical subject heading terms 
and standard keywords were used to build a 
search strategy using relevant terms including: 
‘multiple sclerosis’, ‘Exercise’ and ‘Fatigue’. The 
search strategy was further refined for each 
specific database (Supplementary Appendix 1). 
No restriction was made on the search results 
except that the type of publication was filtered 
to ‘any type of review’. In addition, the refer-
ence lists of the reviews were handsearched for 
any additional potentially relevant articles.
●● Inclusion criteria
Reviews evaluating the evidence regarding the 
effects of any type of exercise intervention on 
measure of perceived fatigue, which included 
pwMS and statistically combined the results of 
at least two RCTs, were included in this over-
view. Narrative reviews and systematic reviews 
with qualitative synthesis of the results of RCTs 
and/or studies with other research designs were 
identified and listed (Supplementary Appendix 2) 
but were not included in this metasynthesis.
●● Data collection & analysis
Relevant information was extracted from the 
included reviews and entered into predefined 
data collection forms designed according to 
the guidance from the Cochrane Handbook of 
Systematic Reviews of Interventions. The infor-
mation extracted included review questions 
or objectives, study inclusion/exclusion crite-
ria, characteristics of participants, types and 
details of intervention and comparators, types 
of fatigue outcome measures, study quality 
assessment, statistical methods used, summary 
of results and limitations of the review and/or 
the included studies. Data were collected by one 
author and double checked by other authors.
●● Quality of included reviews & evidence
The methodological quality of included reviews 
was assessed using A Measurement Tool to 
Assess Systematic Reviews (AMSTAR) [12]. The 
tool consisted of 11 items (overall rating score of 
11) and has good face and content validity [12]. 
In a limited test setting, it was shown to have 
good agreement, reliability, construct validity 
and feasibility [13]. All three authors commented 
on the AMSTAR ratings of the included reviews. 
Systematic reviews with an AMSTAR score of 
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Figure 1. Study flow diagram. 
†For a list of excluded reviews, see Supplementary Appendix 3. 
pwMS: People with multiple sclerosis.
Records identied through database searching
(MedLine n = 91, Embase n = 58, Cochrane n = 36, Centre for
review dissemination n = 15, Pedro n = 22)
Additional records identied
through other sources
(n = 1)
Records after
duplicates removed (n = 172)
Records title and abstract
screened (n = 172)
Records excluded
(n = 120)
Full-text articles assessed for
eligibility (n = 52)
Narrative reviews
(n = 16)
Systematic reviews with
qualitative synthesis
(n = 16)
Systematic reviews with
quantitative synthesis (meta-
analysis) (n = 5)
Full-text articles excluded, with
reasons† (n = 15):
– No fatigue outcome measure (n = 5)
– No exercise intervention (n = 4)
– Review protocol (n = 2)
– Not on pwMS (n = 2)
– Overview of reviews (n = 1)
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8–11 were ranked as high, 4–7 as medium and 
less than three as low methodological quality [14].
The quality of evidence presented in the 
reviews was assessed using the Grading of 
Recommendation Assessment, Development and 
Evaluation (GRADE) approach [15,16]. According 
to GRADE, the quality of the overall evidence is 
assessed based on the rating of five main domains: 
limitation in design, publication bias, precision in 
results, indirectness and inconsistency of results.
Results
●● Characteristics of included reviews
After adjusting for duplicates, 172 records were 
included for initial title and abstract screening. 
Records that clearly did not meet the inclusion 
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Table 1. Characteristics of included reviews.
Characteristics Study
Heine et al. (2015) Cramer et al. (2014) Asano & Finlayson 
(2014)
Pilutti et al. (2013) Motl & Gosney (2008)
Types of studies (n) RCTs including 
Crossover designs (36)
RCT (5) RCT (10)† RCT (17) Pre-post study (3), 
controlled trial (4), both 
pre-post and controlled 
(1)
Date assessed as up 
to date
November 2014 March 2014 August 2013 October 2012 November 2006
Population
n (IG vs CG) Exercise versus 
control: 1603 (969 
vs 34), Exercise 
versus nonexercise 
control: 1325 (831 vs 
494), exercise versus 
exercise: 278 (138 vs 
140)
Yoga versus 
control: 203 (109 
vs 94), yoga vs 
exercise: 369 (119 
vs 250)
233 (112 vs 121) 568 347
Age (years) 18–65 32.2–54.4 34–50 NR NR
Sex (female; %) NR NR 55–100% NR NR
Types of MS (n) NR (9), RRMS (5), SPMS 
+ PPMS (3), RRMS + 
SPMS (6), all types (13)
NR Unclear (6), > 90% 
RRMS (3), 31% RRMS 
(1)
NR NR
EDSS EDDS < 6.5 in 35 
studies, 6.5< EDDS< 
8.5 in one study
NR Minimal to moderate 
(EDDS range: 3–7.5)
NR NR
Baseline fatigue Predefined in one 
study
NR Predefined in one 
study
NR NR
Intervention:
– Type (n studies) Endurance (11), 
muscle power training 
(4), task-oriented (2), 
mixed training (6), 
other training (9)
Hata yoga (2), 
Lyengar yoga (1), 
yoga (2)
Various exercise 
interventions
Various exercise 
interventions
Aerobic (6) 
Nonaerobic (1) 
Aerobic and 
nonaerobic(1)
– Duration of 
treatment (n studies)
Endurance: >3 weeks 
to <6 months (11), 
muscle power 
training: 8–12 weeks 
(4), task-oriented 
training: NA (2), mixed 
training: 2–26 weeks 
(6), other 
training: NR (9)
6–12 weeks (3), 24 
weeks (2)
<6 weeks (2), 6–12 
weeks (6), 24 weeks 
(2)
<6 weeks (3), 6–12 
weeks (8), 12–26 
weeks (4), NR (2)
3 months or more (6), 
<3 months (2)
– Timing and intensity 
(n studies)
Endurance: 1–5×/
week, Muscle power 
training: 2–5×/
week, task-oriented 
training: NR, mixed 
training 2–5×/week, 
other training: NR
1×/week for 60–90 
min (4), 3 ×/week for 
60–70 min (1)
Range: 1–4x/week for 
<30–90 min
1× or 2×/week (6), 
3×/week (7), 3–6×/
week (4)
< 90 min/week (6), > 90 
min/week (1), NR (1)
†Studies included a purpose statement saying that the intervention targeted fatigue/energy levels.
CG: Control group; EDDS: Expanded Disability Status Scale; ES: Effect size; FSMC: Fatigue scale for motor and cognitive function; FSS: Fatigue Severity Scale; IG: Intervention group; 
MFI: Multidimensional fatigue inventory; MFIS: Modified Fatigue Impact Scale; MS: Multiple sclerosis; NR: Not reported; POMS; Profile of Mood State; PPMS: Primary progressive 
multiple sclerosis; QoL: Quality of life; RCT: Randomized control trial; RRMS: Relapsing-remitting multiple sclerosis; SF 36: Short Form (36); SPMS: Secondary progressive multiple 
sclerosis.
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Characteristics Study
Heine et al. (2015) Cramer et al. (2014) Asano & Finlayson 
(2014)
Pilutti et al. (2013) Motl & Gosney (2008)
Comparison (n studies) Exercise versus control 
(36), exercise versus 
non-exercise control 
group (27), exercise 
versus exercise (9)
No intervention/
Usual care (4), 
aerobic (2), aerobic 
+ resistance (2) and 
climbing (1)
No-intervention/usual 
care (5), other exercise 
– for example stretch, 
balance, yoga, home 
exercise (5)
No-intervention/
usual care
Either no control or 
no-exercise control 
group
Fatigue measure:
– Type (n studies) Endurance: FSS (7), 
MFIS (5), POMS fatigue 
subscale (2), FSMC (2) 
and MFI (1), muscle 
power training: FSS 
(4) and MFIS (4), task-
oriented training: FSS 
(2), mixed training: FSS 
(7), MFIS (6)
MFIS, (3), MFI (1), 
FSS (1)
FSS (6), MFIS (3), MFI 
(1)
FSS (7), MFIS (5), 
MSQOL (4), SF 36 
– vitality (4), POMS 
vigor/fatigue (2), 
MFI (2), Hamburg 
QoLMS (1), Sickness 
impact Profile-
alertness (1)
FSS (3), MFIS (3), MFI (1), 
Visual Analog Fatigue 
Scale (1)
Review limitation Lack of trials 
specifically targeted 
fatigue 
Only three studies 
measured fatigue as a 
primary outcome 
Possible effect of 
low methodological 
quality of studies 
on ES 
Presence of small 
study effect 
Underpowered 
studies with small 
sample sizes 
Only two studies 
included participants 
with fatigue at 
baseline
Limited overall 
study/sample size 
Insufficient 
reporting and/or 
low methodological 
quality of the 
included studies 
Studies in grey 
literature were not 
included 
Type of MS or level 
of disability was not 
reported.
Small sample size of 
the included studies 
Only one study 
included participants 
with fatigue at 
baseline 
Lack of reporting of 
quality of evidence 
Result for exercise 
subgroups not 
reported
Few studies with 
patients with 
preselected level of 
fatigue 
Result for exercise 
subgroups not 
reported
Combining controlled 
and noncontrolled 
effect sizes 
Effect on fatigue was 
analyzed as moderator 
of overall QoL outcome
†Studies included a purpose statement saying that the intervention targeted fatigue/energy levels.
CG: Control group; EDDS: Expanded Disability Status Scale; ES: Effect size; FSMC: Fatigue scale for motor and cognitive function; FSS: Fatigue Severity Scale; IG: Intervention group; 
MFI: Multidimensional fatigue inventory; MFIS: Modified Fatigue Impact Scale; MS: Multiple sclerosis; NR: Not reported; POMS; Profile of Mood State; PPMS: Primary progressive 
multiple sclerosis; QoL: Quality of life; RCT: Randomized control trial; RRMS: Relapsing-remitting multiple sclerosis; SF 36: Short Form (36); SPMS: Secondary progressive multiple 
sclerosis.
Table 1 (cont.). Characteristics of included reviews.
criteria (n = 120) were excluded and the full 
text of the remaining 52 records were reviewed. 
Five of these included reviews statistically 
combined the results of the studies and were 
retained in this overview for further analysis. 
Fifteen records were further excluded due to 
the reasons stated in Figure 1. The remaining 
records were either systematic reviews with 
qualitative synthesis (n = 16) or narrative 
reviews (n = 16; see Supplementary Appendix 2 
for a detailed list). No further records were 
found after handsearching the reference lists 
of the narrative and systematic reviews.
Included trials in the reviews
A summary description of included reviews 
is presented in Table 1. Cramer et al., Pilutti 
et al. and Asano et al. included five, 17 and 
10 RCTs, respectively [8,17,18]. These reviews 
included RCTs only. In the other two reviews, 
Heine et al. included both RCTs and rand-
omized crossover designs (n = 36 studies) [19], 
while Motl and Gosney included both RCTs 
and prepost trials (n = 8 studies) [20]. The earli-
est and the most recent reviews were assessed as 
up to date on November 2006 and November 
2014, respectively. A total of 46 unique trial 
Neurodegener. Dis. Manag. (2017) 7(3)224
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reports were included in five reviews of which 
19 reports appeared in two or more reviews.
Population
The included reviews reported on three 
dif ferent comparisons (see comparison 
group section below) and the total number 
of participants in each of these comparisons 
ranged from 203 to 1603 with a median of 
358 (Inter-quartile range; IQR = 490). In the 
three reviews which reported the age of partici-
pants, one included studies with a wide range 
of sample age (18–65 years) [19], whereas, the 
other two reviews by Cramer et al., Asano 
and Finlayson included studies with partici-
pants ranging from 32–54 to 34–50 years old, 
respectively [8,17]. Two reviews stated the types 
of MS in the included studies [8,19]. However, 
the types of MS in the majority of the trials 
included in these two reviews were unclear 
or not reported. The trials which did report 
the type of MS, mostly included participants 
with relapsing-remitting MS. The same two 
reviews [8,19] are also the only reviews which 
reported degree of disability of the pwMS in 
the included studies. Participants in the studies 
included in the review were minimally to mod-
erately affected by MS (Expanded Disability 
Status Scale; EDSS levels ranging from 0 to 
6.5). No reviews included studies with pwMS 
which were more severely affected, in other 
words, those unable to walk (EDSS of 7 and 
higher). Of all included trials in the reviews, 
only one trial [21] included participants with a 
predefined level of fatigue (score of 45 or above 
out of 84 on the Modified Fatigue Impact 
Scale questionnaire) and this study appeared 
in two reviews [8,19].
Types & mode of intervention
While the majority of the reviews included 
trials on a wide range of exercise interventions, 
one review included only studies on the effects 
of yoga [17]. The review by Motl and Gosney 
categorized the interventions in the included 
trials as either aerobic or nonaerobic [20]. 
Heine et al. grouped the exercise interventions 
as: endurance, muscle training, task-oriented 
training, mixed and ‘other’ (i.e., hippotherapy, 
balance training, yoga, inspiratory muscle 
training, motor learning, sports climbing and 
robot-assisted gait training) [19]. Aerobic exer-
cise was the most common type of interven-
tion in all reviews except the review on yoga 
by Cramer et al. [17]. The majority of the trials 
implemented intervention durations of between 
6 and 12 weeks. The intervention frequency 
and session duration varied among the tri-
als, ranging from once a week to five-times a 
week with total session duration spanning of 
30–90 min per week. There was a lack of infor-
mation on long-term follow-up in all reviews 
and the included studies.
Comparison group
The reviews included in this metasynthesis 
reported a total of eight pooled effect sizes 
for exercise versus one or more of three differ-
ent comparators. Four reviews calculated the 
pooled effect size (ES) for exercise interven-
tions compared with nonexercise/usual care 
control group [17–20]. In addition, Heine et al. 
and Cramer et al. calculated pooled ES for 
the effect of exercise (yoga in the case of 
Cramer) compared with other exercise control 
conditions [17,19]. In two reviews the exercise 
interventions were compared with any type 
of control group (including either exercise or 
nonexercise group) [8,19].
Outcome measure
The most frequently reported fatigue outcome 
measure, reported in 37 of the 46 trials, was 
Fatigue Severity Scale, included in all eight 
comparisons made in the reviews followed by 
Modified Fatigue Impact Scale, reported in 25 tri-
als. The remaining outcome measures included: 
multidimensional fatigue inventory (reported 
in 6 trials), Profile of Mood State Fatigue sub-
scale (four trials), SF-36 vitality (four trials), MS 
Quality of life (QoL; four trials) and Hamburg 
QoLMS, Sickness Impact Profile-alertness and 
Visual Fatigue Analog Scale, each in one trial. 
All reviews reported the short-term effect of exer-
cise on fatigue (i.e., pre- and postintervention).
●● Methodological quality of included 
reviews
Methodological quality varied among the 
included reviews (see Table 2). Two reviews were 
rated as having high methodological quality; with 
AMSTAR ratings of 10 and 9, respectively [17,19]. 
The reviews conducted by Pilutti et al. and 
Asano et al. exhibited medium methodological 
quality (AMSTAR: 5) [8,18]. The lowest rating 
of methodological quality was assigned to Motl 
and Gosney’s review (AMSTAR: 2) [20]. None 
of the reviews was scored as having a conflict 
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Table 2. AMSTAR rating.
Question Heine et al. (2015) Cramer et al. 
(2014)
Asano & 
Finlayson (2014)
Pilluti et al. (2013) Motl & Gosney 
(2008)
1  Was an ‘a priori’ design provided? Y Y N N N
2 Was there duplicate study selection 
and data extraction?
Y Y Y CA CA
3 Was a comprehensive literature 
search performed?
Y Y CA Y Y
4 Was the status of publication 
(i.e., grey literature) used as an 
inclusion criterion?
Y N N N N
5 Was a list of studies (included and 
excluded) provided?
Y Y N N N
6 Were the characteristics of the 
included studies provided?
Y Y Y Y N
7 Was the scientific quality of the 
included studies assessed and 
documented?
Y Y N Y N
8 Was the scientific quality of the 
included studies used appropriately 
in formulating conclusions?
Y Y N Y N
9 Were the methods used to combine 
the findings of studies appropriate?
Y Y Y Y Y
10 Was the likelihood of publication 
bias assessed?
Y Y Y CA N
11 Was the conflict of interest 
included?
CA N CA CA N
12 Overall score 10 9 5 5 2
CA: Cannot Answer; N: No; Y: Yes.
of interest in either the review or the included 
trials. Four of the five reviews did not include 
grey literature and/or did not search secondary 
sources other than online databases. Three of the 
five reviews did not provide an a priori design or 
a list of excluded studies.
●● Risk of bias assessment
One review assessed the risk of bias (RoB) 
among their included studies using both the 
Cochrane RoB assessment tool and PEDro 
checklist [19]. Two reviews reported the 
methodological quality of trials using Cochrane 
RoB assessment tool only [8,17] and one review 
used PEDro only [18]. Motl and Gosney did 
not report on the methodological quality of 
their included trials. Allocation concealment 
and blinding of participants, personnel or out-
come assessment were reported as ‘high risk’ or 
‘unknown risk’ of bias for the majority of the 
trials included in all four reviews who reported 
RoB (Table 1). Only Heine et al. commented on 
the quality of evidence. The authors employed 
the GRADE approach for evaluating the qual-
ity of body of evidence and reported, on this 
basis, the evidence for the favorable effect of 
exercise therapy on fatigue was moderate.
●● Effect of exercise on MS fatigue
In the five reviews in this synthesis, the pooled 
effect sizes for eight comparisons were calcu-
lated. These eight comparisons were grouped in 
this overview in three categories based on the 
type of control group(s), Table 3. The results are 
explained in the following sections.
Exercise versus nonexercise/usual care 
control/no control
The reviews reporting the effect of exercise on 
MS fatigue, when compared with no exercise 
or usual care conditions, showed a significant 
moderate random effect in favor of exercise. 
Heine et al., Cramer et al. and Pilutti et al. 
calculated the pooled effect sizes (95% CI) as 
-0.58 (-0.8, -0.34), -0.52 (-1.02, -0.02) and 
-0.45 (-0.22, -0.68), respectively. All three 
reviews adopted a random effect model as there 
was significant heterogeneity among included 
studies (see Table 3). It is worth noting that 
Cramer et al. included only trials on yoga as 
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Exercise for fatigue in multiple sclerosis
Intervention/
Comparison 
Study (year) Effect size 
(95% CI)  
p-value  Heterogeneity 
test  
p-value  Number of 
participants 
(trials) 
Quality of the 
evidence 
(GRADE)†
Comments 
Exercise versus 
ontrol
Heine et al. (2015)  -0.35 (-0.13, 
-0.57)
0.0001 I2 = 73% <0.01 1603 (36) ⊕⊝⊝⊝ Very 
low‡,§,¶
Limitation −1 
Indirectness −1 
Inconsistency −1
Asano and 
Finlayson 
(2014)
-0.57 (-0.1, 
-1.04)
0.02 Q = 26.39, 
I2 = 65%
0.003 233 (10) ⊕⊝⊝⊝ Very 
low‡,¶,#
Limitation −1 
Imprecision −1 
Inconsistency −1
Exercise versus 
nonexercise/usual 
care/no control
Heine et al. (2015) -0.58 (-0.34, 
-0.81)
0.0001 I2 = 58% <0.01 1325 (27) ⊕⊝⊝⊝ Very 
low‡,§,¶
Limitation −1 
Indirectness −1 
Inconsistency −1
Pilutti et al. (2013) -0.45‡‡ 
(-0.22, -0.68)
<0.001 Q = 29.9 0.019 568 (17) ⊕⊝⊝⊝ Very 
low‡,§,¶
Limitation −1 
Indirectness −1 
Inconsistency −1
Cramer et al. (2014) -0.52 (-0.02, 
-1.02)
0.04 χ2 = 7.3, 
I2 = 60%
0.06 203 (4) ⊕⊝⊝⊝ Very 
low‡,§,¶,#
Limitation −1 
Indirectness −1 
Inconsistency −1 
Imprecision −1
Motle and Gosney 
(2008)
-0.19‡‡,§§ 
(-0.01, -0.39)
significant¶¶ Q = 20.53 0.0001 347 (8) ⊕⊝⊝⊝ Very 
low‡,§,¶,#,††
Limitation −1 
Indirectness −1 
Inconsistency −1 
Imprecision −1
Exercise versus 
other exercise 
control
Heine et al. (2015) 0.28 (0.00, 
-0.56)
0.047 I2 = 23% 0.24 278 (9) ⊕⊝⊝⊝ Very 
low‡,§,#
Limitation −1 
Imprecision −1 
Indirectness −1
Cramer et al. (2014) 0.03 (-0.24, 
0.30)
0.83 χ2 = 4.59, 
I2 = 13%
0.33 369 (5) ⊕⊝⊝⊝ Very 
low‡,§,#
Limitation −1 
Imprecision −1 
Indirectness −1
†The argumentation for downgrading the grades of evidence is provided in the footnotes.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
‡Crucial limitation on the blinding of the intervention to the participants, personnel and outcome assessors in most of studies. There is limitation in allocation concealment in 
most studies.
§Patients included did not report baseline fatigue. Fatigue was secondary outcome in majority of studies.
¶Statistical tests of heterogeneity have a low p-value and I2 value is large or minimal or no overlap of confidence intervals.
#Total sample size is small.
††High risk of bias due to inclusion of before and after trials.
‡‡Hedges g
§§Authors tested the effect of exercise on QoL and tested for the effect of fatigue instrument as a moderator of the QoL effect size.
¶¶p-value not reported.
GRADE: Grading of Recommendation Assessment, Development and Evaluation.
an exercise intervention, whereas the other two 
reviews included trials on various types of exer-
cise training. Besides, Pilutti et al., Motle and 
Gosney adjusted for small sample size which 
calculated ES in accordance with Hedges g.
Motl and Gosney included both controlled 
and noncontrolled trials and stated that the 
effect of exercise intervention on QoL and 
fatigue as a measure of QoL was statistically 
signif icant. They further tested the effect 
of presence of fatigue outcome measure as 
a moderator variable in order to examine 
whether these can explain the amount of the 
variability in the overall magnitude of change 
in QoL. According to the authors, the overall 
effect size was significantly influenced by the 
type of QoL outcome measure instruments 
used in the studies and concluded that there 
was a significant effect for fatigue ‘as a measure 
of QoL’. The pooled effect sizes (95% CI) for 
fatigue as a QoL moderator was calculated to 
be -0.19 (-0.01, -0.39).
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Exercise versus other exercise control
Cramer et al. reported that effect of yoga on 
fatigue compared with other exercise types 
(i.e., climbing, treadmill, aerobic and resistance 
training) was not significant, ES (95% CI): 
0.03 (-0.24, -0.30), p = 0.83. The same non-
significant results were reported by Heine et al. 
for effect of exercise interventions compared 
with other types of exercise; ES (95% CI): 0.28 
(0.00, -0.56), p = 0.047. The exercise interven-
tion that was the primary focus of a trial was 
considered as an experimental intervention. 
The test of heterogeneity was not significant for 
either review. Additionally, both reviews were 
rated as having high methodological quality.
Exercise versus exercise or nonexercise control
Two reviews reported the pooled effect estimate 
for the effect of exercise interventions compared 
with control groups of exercise and/or nonex-
ercise conditions [8,19]. Asano and Finlayson 
reported a significant moderate random effect 
of a wide range of exercise interventions 
(i.e., aerobic, aquatic and inspiratory muscle 
exercise; vestibular rehabilitation program; 
progressive resistance training; climbing; and 
yoga) on fatigue. The pooled ES (95% CI) was 
-0.57 (-0.1, -1.04) indicating a reduction on 
fatigue, with a significant heterogeneity (Q = 
26.39, I2 = 65%, p = 0.003). This ES was larger 
than that of random pooled ES calculated by 
Heine et al. (ES [95% CI]: -0.35 [-0.57, -0.13], 
heterogeneity: I2 = 73%, p < 0.01). Based on 
AMSTAR rating, Heine et al., Asano and 
Finlayson reviews were rated as having high and 
moderate methodological quality, respectively.
●● Other results
Heine et al. [19] performed a sensitivity analysis 
to assess the effect of the methodological qual-
ity of their included trials on the effect size. 
For this analysis they included trials com-
paring exercise to nonexercise control with 
PEDro score >5. Data from 14 studies with 
total number of 495 participants in the exer-
cise group and 306 participants in the control 
group were used. The results showed a larger 
heterogeneous effect (I2 = 72%, p-value < 0.01), 
ES (95% CI): -0.64 (-0.95, -0.32), p < 0.01 
than the overall effect size of -0.52, indicating 
that higher methodological quality produced a 
higher effect size. Cramer et al. also conducted 
a sensitivity analysis on the blinding of outcome 
measurement (detection) bias and found that 
the intervention effect was not significant when 
only trials (n = 3) with low detection bias were 
entered for calculating the effect size (yoga vs 
usual care, ES [95% CI]: -0.32 [-0.72, -0.08], 
p = 0.12, heterogeneity: I2 = 36%, p = 0.21). 
The authors stated that no study had low risk 
of selection or attrition biases.
Furthermore, Heine et al. [19] in another set 
of sensitivity analysis, on the type of exercise 
training undertaken (i.e., endurance, muscle 
power, task oriented, mixed training and other 
training groups), reported that the mixed 
training (ES [95% CI]: -0.73 [-1.23, -0.23], 
p < 0.01, heterogeneity: I2 = 82%, p < 0.01) and 
‘other’ training (ES [95% CI]: -0.54 [-0.79, 
-0.29], p < 0.01, heterogeneity: I2 = 45%, 
p = 0.07) showed a larger effect of exercise on 
fatigue than the endurance exercise (ES [95% 
CI]: -0.43 [-0.69, -0.17], p = 0.004, hetero-
geneity: I2 = 28%, p > 0.18), muscle power 
training (ES [95% CI]: 0.03 [-1.02, -0.33], 
p = 0.93, heterogeneity: I2 = 70%, p > 0.02) 
or task oriented training (ES [95% CI]: -0.34 
[-1.02, -0.33], p > 0.05, heterogeneity: I2 = 0%, 
p > 0.05). However, the subgroup analysis did 
not show a statistically significant difference 
between these groups.
●● Quality of evidence
Based on GRADE assessment, the quality 
of evidence was rated ‘very low’ for all three 
comparisons. We lowered the evidence qual-
ity rating due to the RoB (limitation), lack 
of applicability of results, in other words, 
‘indirectness’, for all reported effect sizes. 
Heterogeneity of results was also a concern for 
exercise training effect compared with either 
any control or nonexercise/usual care control 
group. Furthermore, apart from two compari-
sons in Heine et al. review [19], the total sam-
ple size in the reviews was small (n <200) and 
the majority of the trials were underpowered, 
therefore; these comparisons were rated down 
for imprecision, Table 3.
Discussion & conclusion
The results of this synthesis of reviews suggest 
that the exercise interventions have a moderate 
effect on ameliorating fatigue in pwMS when 
compared with usual care or a no-exercise 
comparison group [17–19]. This was concluded 
in two reviews with high methodological qual-
ity [17,19] and one moderate quality review [18]. 
However, the results should be interpreted with 
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caution because of high RoB, poor applicability 
of results, heterogeneity and small sample size 
in the RCTs on which this evidence is based. 
Blinding is not possible in exercise studies due 
to the nature of the intervention, and in the 
majority of the studies, authors failed to report 
whether the group allocation was concealed or 
whether the outcome assessors were blind to 
allocation. Furthermore, with one exception [21] 
none of the studies used the inclusion criterion 
that participants should be assessed as fatigued 
on study entry, and in the majority of trials, the 
intervention was not specifically designed to 
target fatigue, hence fatigue was measured as a 
secondary outcome.
The review by Asano and Finlayson included 
only those trials in which there was a ‘clear 
statement’ indicating that intervention was 
designed to target fatigue. Interestingly, the 
pooled effect size showed a moderate effect of 
exercise (Standardised mean difference; SMD: 
-0.57, 95% CI: -0.1 to -1.04) when compared 
with any type of comparison group (includ-
ing exercise and nonexercise groups), which 
was larger than that of the reported effect size 
in Heine et al. review (SMD: -0.35, 95% CI: 
-0.13 to -0.57). This may plausibly indicate that 
the effect of exercise training on self-reported 
fatigue may be larger when the intervention is 
designed to target fatigue. However, after close 
inspection of the aim and rationale of the studies 
included by Asano and Finlayson [8], only two 
studies [21,22] reported an intervention which spe-
cifically targeted fatigue as the main outcome.
There was a significant heterogeneity in the 
results most likely due to the diversity in type/
mode of exercise interventions, comparison 
groups and/or study population. Most stud-
ies included 30– 50-year-old participants 
of moderate disability with nonprogressive 
MS. Heterogeneity was higher when reviews 
included both exercise and nonexercise con-
trol conditions into the comparison, compared 
with when only nonexercise/usual care control 
condition was used. In contrast, heterogeneity 
was not significant in two reviews, with high 
AMSTAR ratings, when exercise was compared 
with the other exercise control group. Despite 
a relatively large number of studies in the 
included reviews, there is still a paucity of infor-
mation on which type of exercise intervention/s 
and with what specific combination of exercise 
duration, frequency and intensities might be 
most effective in reducing MS-related fatigue. 
Asano and Finlayson [8] commented that those 
studies which reported larger effect sizes (ES 
>0.81) assessed a large variety of exercise train-
ing types and therefore no definitive conclu-
sion could be made regarding type and pre-
scription characteristics of exercise training 
that would be more effective to reduce fatigue. 
Pilutti et al. [18] concluded that aerobic train-
ing intervention elicited lower effect sizes 
compared with resistive training or combined 
mode, whereas; Heine et al. [19] reported that 
aerobic and mixed training (aerobic and resis-
tive) and other training such as yoga, robotics 
and balance training showed significant effects, 
with mixed training showing the highest effect 
of all (ES: -0.73, 95% CI: -0.23 to -1.23). 
Cramer et al.’s review [17] on yoga suggested 
that yoga can be equally effective as other 
exercise training interventions on both patient 
reported and objective measured outcomes such 
as mobility and cognitive function.
In addition to the aforementioned limitations, 
there are few important issues with the avail-
able exercise studies that preclude meaningful 
interpretations regarding most effective type of 
exercise to treat fatigue. First, the vast major-
ity of the trials failed to include a sufficiently 
detailed description of the exercise training 
intervention characteristics such as supervision 
of exercise, progression and overload training 
principles, and intervention fidelity and adher-
ence. Second, there is lack of studies in which 
the intervention is guided by a theory regarding 
the possible pathophysiological or behavioral 
mechanisms through which the intervention 
is thought to influence either primary or sec-
ondary fatigue. Moreover, very few studies are 
designed to test these theories. In a recent scop-
ing review, including 234 studies, Langeskov-
Christensen et al. reported that only three 
studies explicitly investigated the potential 
pathophysiological pathways explaining the 
effect of exercise on MS-related fatigue [10]. 
These three studies all showed an effect of a 
variety of exercise intervention (aerobic and 
resistive) on the immunologic changes due 
to increase in anti-inflammatory factors. The 
authors also proposed other patho physiological 
mechanistic pathways that could potentially 
explain the effect of the exercise on fatigue 
including cardiovascular, neuroendocrine and 
neurotrophic changes. Furthermore, it was 
hypothesized that secondary MS fatigue could 
be ameliorated through an increase in fitness 
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and motor efficiency, improved sleep quality 
and changes in depressive symptoms.
The other main challenge that impedes 
meaningful conclusions in fatigue studies is the 
lack of consistent measurement of perceived 
fatigue using psychometrically sound outcome 
measures. Fatigue is considered multidimen-
sional that could result from changes in central 
neural system, psychological and physiological 
factors [23]. Often the current self-report fatigue 
scales and questionnaires suffer from construct 
contamination and measure one or only few 
dimensions of fatigue. In a systematic review 
into the evidence of psychometric properties of 
outcomes of fatigue in pwMS and Parkinson’s 
disease, Elbers et al. reported that there is lim-
ited evidence for the psychometric properties 
of the Fatigue Severity Scale and Modified 
Fatigue Impact Scale, the most common self-
reported fatigue measures in MS studies [24]. 
The authors concluded that the fatigue scale 
for motor and cognitive functions has moderate 
evidence for its internal consistency and struc-
tural validity, while the unidimensional fatigue 
impact scale has moderate evidence for its reli-
ability and structural validity in pwMS. Apart 
from the relative lack of psychometric sound 
measure for self-reported fatigue in pwMS, 
studies on measuring motor fatigability show 
inconsistency in the concept being assessed, 
disparity of exercise protocols and fatigability 
outcome, limited information of psychometric 
properties of outcome measures and lack of cut-
off value showing clinically significant motor 
fatigability [25]. Such outcomes may contribute 
to understanding of some of the mechanisms 
through which exercise interventions could 
potentially result in a decrease in self-reported 
fatigue in pwMS.
Considering the limitations of the current 
literature, it is suggested that future studies 
exploring the benefits of exercise interventions 
to reduce fatigue in pwMS are powered high 
quality randomized trials of exercise modalities 
including participants with a predefined level 
of fatigue, with detailed description of both 
participant characteristics and intervention 
mediators, such as overload components, pro-
gression, duration and mode of delivery [26]. 
Such studies should also report not only on 
outcomes of perceived fatigue, but also motor 
fatigability and other MS symptoms associ-
ated with fatigue such as depression and assess 
these outcomes both short and long term. 
This will then allow future reviews to system-
atically characterize and explore the nuanced 
detail of exercise training program compo-
nents used [26] to enable better categorization 
of exercise intervention types that may be 
hypothesized to favorably affect fatigue. This 
may not only result in a reduction of hetero-
geneity of the results and thus an increase in 
the quality of evidence generated, but may 
also help in understanding which component 
of the exercise intervention is more effective 
in reducing MS fatigue, and in which group 
of pwMS. Furthermore, it is suggested that 
future high quality reviews focus on explor-
ing what component/s or mediators of exercise 
intervention and through which mechanistic 
pathway/s, may have the greatest effect in miti-
gating MS-related fatigue.
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